Clinical trials
Completed Observational Amyloidosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2021 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Cleveland Clinic | 4 |
| Ionis Pharmaceuticals, Inc. | 2 |
| Pfizer | 2 |
| Alnylam Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Boston Medical Center | 1 |
| Daniel Bernstein | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| Hospital Italiano de Buenos Aires | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 29 |
| Immunoglobulin Light-chain Amyloidosis | 8 |
| Cardiomyopathies | 6 |
| Alzheimer Disease | 3 |
| Carpal Tunnel Syndrome | 3 |
| Multiple Myeloma | 3 |
| Polyneuropathies | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Heart Failure | 2 |
| Monoclonal Gammopathy of Undetermined Significance | 2 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.